DataPile investor atlas
Angel investors & venture capitalists in New Jersey, United States
Last updated 27-10-2025. Data refreshed weekly.
3
Matches for your filters
27
Total investors in region
3,050
Profiles tracked nationwide
27
Based in New Jersey
Princeton (3)
Largest investor hub
Princeton Equity Group, HAF
Notable firms
Refine investor results
Toggle multiple filters to narrow the directory instantly.
Location
States & regions
Cities
Industry focus
We found 3 investors based in Princeton.
Market intelligence
- Most active investment themes in New Jersey, United States: venture capital & private equity, mechanical or industrial engineering, information technology & services.
- 3 profiles are headquartered in Princeton, making it the busiest hub in New Jersey, United States.
- Featured firms include Princeton Equity Group, HAF, Compucom, Keller Williams Realty, LLC.
Explore states in United States
California
797
New York
628
Massachusetts
200
Texas
180
Florida
128
Illinois
95
Pennsylvania
87
Washington
70
Colorado
56
Ohio
49
Michigan
47
North Carolina
46
District of Columbia
45
Georgia
43
Maryland
42
Virginia
36
Tennessee
36
New Jersey
27
Minnesota
27
Utah
25
Arizona
24
Connecticut
24
Nevada
19
Oregon
18
Missouri
18
Indiana
16
Wisconsin
13
South Carolina
12
Arkansas
9
Kentucky
8
New Hampshire
8
Nebraska
7
Louisiana
6
Oklahoma
5
Rhode Island
5
Alabama
4
Hawaii
4
Wyoming
3
Idaho
3
Iowa
3
Vermont
3
Kansas
3
Delaware
2
Montana
2
Maine
2
New Mexico
1
Mississippi
1
Alaska
1
Investor hotspots
Frequently mentioned firms
Showing 1 – 3 of 3 investors
Princeton Equity Group
- Focus areas
-
venture capital & private equity
- Location
- Princeton, New Jersey, United States
CT
Brown Brothers Harriman
- Focus areas
-
financial services private banking investment management investor services financial services wealth management asset servicing investment banking private equity commercial banking advisory services global custody securities administration high-net-worth individuals family offices institutional investors capital partner solutions personalized service long-term relationships risk management operational efficiency alternative fund services etf services client success partnership culture sophisticated investors family-owned businesses succession planning technology solutions regulatory compliance client engagement community involvement premium service specialist expertise financial advisory merger and acquisitions trust administration estate planning client-focused approach innovative technology market presence customer loyalty employee satisfaction custody services fund administration securities lending foreign exchange transfer agency regulatory intelligence global markets client experience multi-family office corporate advisory trust services investment strategy endowment management philanthropic advisory values-based wealth planning funding solutions cross-border fund services depositary services alternatives data solutions market insights capital partners financial institutions custom solutions strategic partnerships personalized services expertise and insight long-term investment strategy sustainable investing client-centric approach global reach investment research assets under custody market trends client success stories business continuity planning b2b consulting services capital markets financial consulting management consulting law practice legal services venture capital & private equity
- Location
- Princeton, New Jersey, United States
Bristol Myers Squibb
- Focus areas
-
pharmaceuticals biotechnology innovation great place to work pharmaceuticals research & development healthcare health & wellness life sciences biotechnology: pharmaceutical preparations health care pharmaceutical manufacturing biotech r&d patient-centered b2b biotech research advances acute coronary syndrome pharmaceutical innovation clinical research biotech in inflammatory diseases atrial fibrillation blockbuster drugs immunology government biotech research platforms pharmaceutical and medicine manufacturing biotech innovation hubs cardiovascular blood clotting market leadership biotech in cancer patient resources drug discovery market access research and development healthcare providers oncology biotech manufacturing oncology drugs fibrosis treatments biotech innovation platforms therapeutics secondary stroke prevention fibrosis biotech innovation partnerships risk management biologics biotech clinical development cancer immunotherapy biotech research investments global reach financial reporting biotech partnerships biotech pipeline biopharma biotech research programs biopharmaceutical biotech innovation ecosystem biotech innovation research facilities biotech collaborations biotech in genetic disorders biotech innovation strategies cancer immunotherapy drugs oncology pipeline precision medicine immune system biotech in cardiovascular drug development biotech in neuroscience services innovative medicines biotech research centers biologics manufacturing biotech research initiatives pipeline biotech in metabolic diseases immunology pipeline biotech phase 3 clinical trials biotech in fibrosis biotech in rare diseases global healthcare clinical trials marketed drugs biotech in autoimmune diseases milvexian biotech research collaborations immunotherapy biotech research projects biotech research pipelines biotech research funding targeted therapies cancer therapy medical research neuroscience portfolio biotech research breakthroughs biotech pipeline management blood clotting disorders blood thinners cell therapy car t cell therapy cancer treatment translational medicine health equity licensed agreements generic drugs drug pricing scientific research clinical trial access disease research patient-centered care global health therapeutic areas research pipeline investors corporate responsibility disease state resources global partnerships medical information pediatric implications chronic diseases emergency protocols post-study access prescription assistance stem education community impact environmental sustainability inclusion and diversity corporate governance transparency initiatives shareholder services analyst coverage stakeholder engagement manufacturing distribution medical health wellness & fitness hospital & health care mechanical or industrial engineering
- Location
- Princeton, New Jersey, United States
No investors match the selected filters. Try broadening your criteria or exploring neighbouring ecosystems.
Explore other regions in United States
- California (797)
- New York (628)
- Massachusetts (200)
- Texas (180)
- Florida (128)
- Illinois (95)
- Pennsylvania (87)
- Washington (70)
- Colorado (56)
- Ohio (49)
- Michigan (47)
- North Carolina (46)
- District of Columbia (45)
- Georgia (43)
- Maryland (42)
- Virginia (36)
- Tennessee (36)
- New Jersey (27)
- Minnesota (27)
- Utah (25)
- Arizona (24)
- Connecticut (24)
- Nevada (19)
- Oregon (18)
- Missouri (18)
- Indiana (16)
- Wisconsin (13)
- South Carolina (12)
- Arkansas (9)
- Kentucky (8)
- New Hampshire (8)
- Nebraska (7)
- Louisiana (6)
- Oklahoma (5)
- Rhode Island (5)
- Alabama (4)
- Hawaii (4)
- Wyoming (3)
- Idaho (3)
- Iowa (3)
- Vermont (3)
- Kansas (3)
- Delaware (2)
- Montana (2)
- Maine (2)
- New Mexico (1)
- Mississippi (1)
- Alaska (1)